Evaluation of Carmeda bioactive surface (CBAS), Duraflo II and a novel nonspecific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass.
Yii
M
M
Department of Cardiothoracic Surgery, Hammersmith Hospital, London.
Gourlay
T
T
Fleming
J
J
Matata
B
B
Taylor
K M
KM
D001672:Biocompatible Materials / Q000009:adverse effects*; D002315:Cardiopulmonary Bypass; D015926:Complement C3a / Q000032:analysis; D006801:Humans; D008855:Microscopy, Electron, Scanning; D009504:Neutrophils / Q000502:physiology; D010976:Platelet Count
D001672:Biocompatible Materials; D015926:Complement C3a